About 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid
2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid (PubChem CID 50907908) has the molecular formula C21H14BrNO4S2
and a molecular weight of 488.38 g/mol. Its IUPAC name is 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid.
Molecular Properties
| Compound Name | 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid |
| PubChem CID | 50907908 |
| Molecular Formula | C21H14BrNO4S2 |
| Molecular Weight | 488.38 g/mol |
| Exact Mass | 486.95 |
| IUPAC Name | 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid |
| SMILES | O=C(O)CN1C(=O)/C(=C\c2ccc(/C=C/C(=O)c3ccccc3Br)cc2)SC1=S |
| InChI | InChI=1S/C21H14BrNO4S2/c22-16-4-2-1-3-15(16)17(24)10-9-13-5-7-14(8-6-13)11-18-20(27)23(12-19(25)26)21(28)29-18/h1-11H,12H2,(H,25,26)/b10-9+,18-11+ |
| InChIKey | JCRJAUNBNLIZDI-XLRUTSMRSA-N |
| XLogP | 4.63 |
| TPSA | 74.68 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 488.38 |
| LogP ≤ 5 | 4.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'ene_rhod_A(235)', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Analyze 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid?
The IUPAC name of 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid (CID 50907908) is 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid.
What is the SMILES notation for 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid?
The canonical SMILES for 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid is O=C(O)CN1C(=O)/C(=C\c2ccc(/C=C/C(=O)c3ccccc3Br)cc2)SC1=S.
What is the InChIKey of 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid?
The InChIKey is JCRJAUNBNLIZDI-XLRUTSMRSA-N. The full InChI is InChI=1S/C21H14BrNO4S2/c22-16-4-2-1-3-15(16)17(24)10-9-13-5-7-14(8-6-13)11-18-20(27)23(12-19(25)26)21(28)29-18/h1-11H,12H2,(H,25,26)/b10-9+,18-11+.
What are the key properties of 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid?
2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid has a molecular weight of 488.38 g/mol, XLogP of 4.63, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5E)-5-[[4-[(E)-3-(2-bromophenyl)-3-oxoprop-1-enyl]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid is sourced from PubChem (CID 50907908), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).